Modulation of colon cancer by nutmeg

Area of Science:

• Biochemistry
• Oncology
• Microbiology

Background:

• Colon cancer is a leading cause of cancer mortality.
• Gut microbiota plays a role in cancer development.
• Uremic toxins are implicated in metabolic disorders.

Purpose of the Study:

• To investigate the role of uremic toxins in colon cancer.
• To explore the effects of nutmeg on uremic toxins and tumorigenesis.
• To understand the link between gut microbiota, inflammation, and lipid metabolism in colon cancer.

Main Methods:

• Mass spectrometry-based metabolomics in Apc(min/+) mice.
• Analysis of uremic toxin levels, IL-6 expression, and lipid metabolism.
• Evaluation of nutmeg's effects on tumorigenesis and metabolic markers.

Main Results:

• Four uremic toxins (cresol sulfate, cresol glucuronide, indoxyl sulfate, phenyl sulfate) accumulated in colon cancer mice.
• These toxins correlated with increased IL-6 and lipid metabolism disorders.
• Nutmeg treatment reduced uremic toxins, IL-6, and intestinal tumors, normalizing lipid metabolism.

Conclusions:

• Uremic toxins contribute to inflammation and metabolic dysfunction in colon cancer.
• Nutmeg shows potential for colon cancer chemoprevention by modulating gut microbiota and lipid metabolism.
• Targeting gut microbiota and lipid metabolism offers a strategy for colon cancer prevention.